Medtronic PLC (NYSE: MDT), a leading global player in medical technology, has received a reaffirmed "BUY" rating from Argus Research with a revised price target of $110.
Motilal Oswal’s recent analysis of Max Healthcare Institute Ltd (MAXH) suggests a promising growth trajectory backed by robust revenue generation and strategic expansions across multiple healthcare
Anand Rathi Research has upgraded Narayana Hrudayalaya to a BUY rating with a revised target price of Rs 1,550, offering a potential upside of approximately 30% from its current price of Rs 1,196.